245 related articles for article (PubMed ID: 35000313)
1. [Update in interstitial lung disease 2021].
Huang H
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jan; 45(1):95-99. PubMed ID: 35000313
[TBL] [Abstract][Full Text] [Related]
2. An update on interstitial lung disease.
Mudawi D; Heyes K; Hastings R; Rivera-Ortega P; Chaudhuri N
Br J Hosp Med (Lond); 2021 Jul; 82(7):1-14. PubMed ID: 34338019
[TBL] [Abstract][Full Text] [Related]
3. Progressive fibrotic interstitial lung disease.
Pereira CAC; Cordero S; Resende AC
J Bras Pneumol; 2023; 49(5):e20230098. PubMed ID: 37610955
[TBL] [Abstract][Full Text] [Related]
4. Management of patients with fibrosing interstitial lung diseases.
Morrow LE; Hilleman D; Malesker MA
Am J Health Syst Pharm; 2022 Jan; 79(3):129-139. PubMed ID: 34608488
[TBL] [Abstract][Full Text] [Related]
5. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Approach to Adult Fibrotic Lung Diseases.
Adegunsoye A; Strek ME
Chest; 2016 Dec; 150(6):1371-1386. PubMed ID: 27521738
[TBL] [Abstract][Full Text] [Related]
7. Centrilobular Fibrosis in Fibrotic (Chronic) Hypersensitivity Pneumonitis, Usual Interstitial Pneumonia, and Connective Tissue Disease-Associated Interstitial Lung Disease.
Churg A
Arch Pathol Lab Med; 2020 Dec; 144(12):1509-1516. PubMed ID: 32233994
[TBL] [Abstract][Full Text] [Related]
8. [Update on interstitial lung diseases].
Salinas M; Florenzano M; Wolff V; Rodríguez JC; Valenzuela H; Fernández C; Undurraga Á
Rev Med Chil; 2019 Nov; 147(11):1458-1467. PubMed ID: 32186607
[TBL] [Abstract][Full Text] [Related]
9. [Update in interstitial lung disease 2023].
Huang H
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):44-49. PubMed ID: 38062694
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and management of cough in interstitial lung disease.
Rasheed AZ; Metersky ML; Ghazal F
Expert Rev Respir Med; 2023 Dec; 17(12):1177-1190. PubMed ID: 38159067
[TBL] [Abstract][Full Text] [Related]
11. [Interstitial lung disease revisited].
Jiang HD; Chen B
Zhonghua Yi Xue Za Zhi; 2021 Jun; 101(20):1453-1457. PubMed ID: 34044517
[TBL] [Abstract][Full Text] [Related]
12. [Use of antifibrotic drugs in interstitial lung disease].
Kreutz CP; Gesierich W; Behr J; Kneidinger N
Dtsch Med Wochenschr; 2022 Oct; 147(21):1383-1390. PubMed ID: 36279864
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity pneumonitis: new concepts and classifications.
Churg A
Mod Pathol; 2022 Jan; 35(Suppl 1):15-27. PubMed ID: 34531525
[TBL] [Abstract][Full Text] [Related]
14. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
15. Impact of antigen identification on transplant free survival in interstitial lung disease.
Kypreos M; Batra K; Glazer CS; Adams TN
BMC Pulm Med; 2023 Oct; 23(1):404. PubMed ID: 37880637
[TBL] [Abstract][Full Text] [Related]
16. Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease.
Gibson CD; Kugler MC; Deshwal H; Munger JS; Condos R
Lung; 2020 Aug; 198(4):597-608. PubMed ID: 32591895
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic approach of fibrosing interstitial lung diseases of unknown origin.
Cottin V; Valenzuela C
Presse Med; 2020 Jun; 49(2):104021. PubMed ID: 32437843
[TBL] [Abstract][Full Text] [Related]
18. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Makino S
Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
[TBL] [Abstract][Full Text] [Related]
19. Advances with pharmacotherapy for the treatment of interstitial lung disease.
Comes A; Sgalla G; Perrotta A; Richeldi L
Expert Opin Pharmacother; 2022 Mar; 23(4):483-495. PubMed ID: 34907821
[TBL] [Abstract][Full Text] [Related]
20. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.
Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M
BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
